Interpace Biosciences (IDXG) Competitor Comparison
We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.
Market Capitalization
57 / 58Gross Profits
45 / 52Total Revenue
45 / 57EBITDA
27 / 56Free Cashflow
28 / 56Quick Ratio
50 / 57Earnings per Share
18 / 56Dividend yield
0 / 9Total Cash
52 / 57Performance 3 years
32 / 58Performance 5 years
40 / 58Performance 10 years
55 / 58Linearity 3 years
41 / 58Linearity 5 years
35 / 58Linearity 10 years
42 / 58Total Rank
17 / 58Dividend Rank
12 / 58Valuation Rank
49 / 58Piotroski Rank
22 / 58Muliplier Rank
4 / 58Market Capitalization - IDXG ranking 57 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.